Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitroparaffin transcriptional profiles and toxicokinetics support chemical-specific carcinogenicity assessment.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Estimating safe doses of perfluorooctane sulfonate (PFOS): an international collaboration.

Archives of toxicology·2025
Same author

A human Angelman Syndrome class II pluripotent stem cell line with fluorescent paternal <i>UBE3A</i> reporter.

Frontiers in cell and developmental biology·2025
Same author

In vitro and computational approaches to predict developmental toxicity: Integrating PBPK models with cell-based assays.

Toxicology and applied pharmacology·2025
Same author

Evaluation of a high-throughput in-vitro-to-in-vivo extrapolation (IVIVE) workflow for the prioritization of potential developmental toxicity of chemicals.

ALTEX·2025
Same author

Evaluation of the validity of a perfluorooctane sulfonic acid exposure reconstruction using a measured serum concentration among workers with a wide range of exposure.

Annals of work exposures and health·2024
Same journal

New approach methodologies as first tier in an integrated approach to testing and assessment for non-genotoxic carcinogens.

ALTEX·2026
Same journal

Assessing the FDA's Year One Progress Report on Reducing Animal Testing.

ALTEX·2026
Same journal

Europe's roadmap finally arrives: Long on rigor, short on a clock.

ALTEX·2026
Same journal

Towards advanced in vitro models of testicular steroidogenesis for endocrine disruption testing.

ALTEX·2026
Same journal

Evaluation of EndoSens: A reliable skin sensitization assessment model.

ALTEX·2026
Same journal

Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolism.

ALTEX·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K

Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).

Melvin E Andersen1, Patrick D McMullen1, Martin B Phillips1

  • 1ScitoVation LLC, Durham, NC, USA.

ALTEX
|October 31, 2019
PubMed
Summary
This summary is machine-generated.

New Approach Methodologies (NAMs) offer human-relevant alternatives to animal testing for chemical hazard identification and risk assessment. This study proposes a framework for selecting and applying NAMs based on risk context and desired data outcomes.

Keywords:
risk assessmentNAMsnonanimal approachestiered testing

More Related Videos

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

11.9K
Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

4.1K

Related Experiment Videos

Last Updated: Jan 4, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K
Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

11.9K
Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

4.1K

Area of Science:

  • Toxicology
  • Risk Assessment
  • Computational Biology

Background:

  • The scientific community advocates for replacing traditional animal testing with New Approach Methodologies (NAMs) for hazard identification and risk assessment.
  • NAMs leverage advancements in biological sciences for more human-relevant in vitro and in silico chemical safety evaluations.
  • A gap exists in establishing clear decision criteria for selecting and implementing NAMs within various risk assessment contexts.

Purpose of the Study:

  • To propose application scenarios for NAMs across different risk contexts.
  • To introduce a tiered framework (Levels 1-4) categorizing NAMs and conventional testing approaches.
  • To foster discussion on context-dependent NAM utilization for chemical safety decisions and provide a roadmap for their adequacy.

Main Methods:

  • Categorization of NAMs and traditional methods into four distinct levels based on complexity and data output.
  • Description of each level, including computational screening, in vitro assays, fit-for-purpose assays, and complex multi-dimensional assays.
  • Integration of decision-appropriate exposure assessment tools within each level.

Main Results:

  • A structured, four-level framework for applying NAMs in risk assessment is presented.
  • Each level is defined by the type of assays used and their suitability for different risk assessment needs.
  • The framework aims to guide the selection of appropriate NAMs for specific chemical safety decision-making scenarios.

Conclusions:

  • The proposed framework facilitates the strategic application of NAMs in chemical risk assessment.
  • It addresses the need for context-specific decision criteria to guide NAM implementation.
  • This approach supports the efficient and human-relevant evaluation of chemical safety, moving beyond traditional animal testing.